Unlike myeloid malignancies, in which IDH1/2 and TET2 mutations are often mutually exclusive, IDH2R172 and TET2 mutations are not exclusive and frequently coexist in PTCL [382]. Here, TET2 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.